Enteromix: Russia’s AI-Powered Personalized mRNA Cancer Vaccine Heralding a New Era in Precision Oncology
The Future of Trials: How Artificial Intelligence Is Accelerating Personalized Cancer Vaccines Enteromix, Russia’s groundbreaking personalized mRNA cancer vaccine, has captured global attention by reporting 100 percent safety and remarkable tumor regression in its initial human trials. By harnessing the flexibility of messenger RNA (mRNA) technology and coupling it with cutting-edge artificial intelligence (AI) for…
